Cases & Deals

Astellas sells U.S. manufacturing subsidiary to Avara

Clients Astellas Pharma Inc.

Jones Day advised Astellas Pharma Inc. in the transfer of its wholly owned manufacturing subsidiary Astellas Pharma Technologies, Inc. to Avara Norman Pharmaceutical Services, Inc. Astellas Pharma Technologies, Inc. will be renamed Avara Pharmaceutical Technologies, Inc.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.